Aamer Sandoo

Lecturer
Cardiovascular Physiology
Bangor University
United Kingdom

Professor Cardiology
Biography

Dr Aamer Sandoo is a Cardiovascular Physiologist specialising in clinical research involving patients with autoimmune disease, breast cancer and cardiovascular disease. Aamer, whose background is in cardiac rehabilitation, has spent ten years managing several large clinical research projects in the NHS providing him with extensive experience in outpatient clinical research. Aamer also has considerable expertise in using several non-invasive assessments of blood vessel function including assessment of microvascular perfusion using drug iontophoresis, flow-mediated dilatation, pulse-wave analysis, and carotid ultrasound. Since joining Bangor University in 2014, Aamer was responsible for equipping the Schools Cardiovascular Laboratory with a state-of-the-art laser Doppler imaging scanner, high-resolution ultrasound scanner, and specialist software to measure blood vessel health.

Research Intrest

Since completing his PhD in 2010, Aamer has rigorously examined the reasons why some patients with rheumatoid arthritis develop cardiovascular disease, and as such, has published several key papers in this area. Aamer has a well-established collaboration with Dr Yasmeen Ahmad from the Peter Maddision Rheumatology Centre, Betsi Cadwaladr University Health Board (BCUHB), and Prof. George Kitas from the Dudley Group NHS Foundation Trust, Dudley. Of particular note, Aamer is one of the original members of the ATTAC-RA consortium – an international group tasked with developing an RA-specific cardiovascular risk calculator suitable for use in many countries. Aamer is also interested in the effects of breast cancer medications on blood vessel health and works closely with Dr Catherine Bale from the North Wales Oncology services, BCUHB. Aamer’s research also examines arterial health in aging populations, and he is currently piloting studies which aim to examine the impact of dietary supplements on blood vessel function.

List of Publications
Sandoo A, Kitas GD, Carmichael AR. Breast cancer therapy and cardiovascular risk: focus on trastuzumab. Vascular Health and Risk Management. 2015; 11: 223-8.
Dimitroulas T, Sandoo A, Hodson J, Smith J, Douglas KM, Kitas GD. Associations between asymmetric dimethylarginine, homocysteine, and the methylenetetradydrofolate reductase (MTHFR) C677T polymorphism (rs1801133) in rheumatoid arthritis. Scandinavian Journal of Rheumatology. 2016; 45(4): 267-73.
Dimitroulas T, Sandoo A, Hodson J, Smith JP, Kitas GD. In vivo microvascular and macrovascular endothelial function is not associated with circulating dimethylarginines in patients with rheumatoid arthritis: a prospective analysis of the DRACCO cohort. Scandinavian journal of clinical and laboratory investigation. 2016 May 18;76(4):331-7.